Many potentially efficient drugs have been created to treat neurological disorders, but they cannot be used in practice.
Typically, for a condition such as epilepsy, it is essential to act at exactly the right time and place in the brain. For this reason, the team of researchers led by Christophe Bernard at Inserm Unit 1106, “Institute of Systems Neuroscience” (INS), with the help of scientists at the École des Mines de Saint-Étienne and Linköping University (Sweden) have developed an organic electronic micropump which, when combined with an anticonvulsant drug, enables localised inhibition of epileptic seizure in brain tissue in vitro. This research is published in the journal Advanced Materials.
Drugs constitute the most widely used approach for treating brain disorders. However, many promising drugs failed during clinical testing for several reasons:
- they are diluted in potentially toxic solutions,
- they may themselves be toxic when they reach organs to which they were not initially directed,
- the blood-brain barrier, which separates the brain from the blood circulation, prevents most drugs from reaching their targets in the brain,
- drugs that succeed in penetrating the brain will act in a non-specific manner, i.e. on healthy regions of the brain, altering their functions.
Epilepsy is a typical example of a condition for which many drugs could not be commercialised because of their harmful effects, when they might have been effective for treating patients resistant to conventional treatments .
During an epileptic seizure, the nerve cells in a specific area of the brain are suddenly activated in an excessive manner. How can this phenomenon be controlled without affecting healthy brain regions? To answer this question, Christophe Bernard’s team, in collaboration with a team led by George Malliaras at the Georges Charpak-Provence Campus of the École des Mines of Saint-Étienne and Swedish scientists led by Magnus Berggren from Linköping University, have developed a biocompatible micropump that makes it possible to deliver therapeutic substances directly to the relevant areas of the brain.
The micropump (20 times thinner than a hair) is composed of a membrane known as “cation exchange,” i.e., it has negative ions attached to its surface. It thus attracts small positively charged molecules, whether these are ions or drugs. When an electrical current is applied to it, the flow of electrons generated projects the molecules of interest toward the target area.
The Latest on: Drug delivery system
via Google News
The Latest on: Drug delivery system
- Targeted drug delivery system more effective to treat cancer cells Scientists News Todayon February 26, 2021 at 1:04 am
Chennai: Glioblastoma multiforme (also called glioblastoma) is the most common and aggressive form of primary brain tumour and it's the most common type of malignant brain tumour among adults. Now ...
- Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinomaon February 25, 2021 at 7:01 am
In this study, we synthesized PLA-PEI micelles which was co-loaded with an anticancer drug, camptothecin (CPT), and survivin-shRNA (sur-shRNA). The hydrophobic CPT was encapsulated in the core of the ...
- Brain targeted system for delivery of highly toxic anti-cancer drugon February 25, 2021 at 4:08 am
Targeted delivery of anti-cancer drug to a localised tumor site has shown to improve the effectiveness of treatment as it concentrates drug at their site of action, and thus reducing side effects at ...
- Milestone Scientific Inc. Announces Breakthrough CompuPulse System and Receives Notice of Allowance for U.S. Patenton February 24, 2021 at 12:23 pm
CompuPulse integrates CompuWave™ technology with a manual syringe to verify needle and catheter placementROSELAND, N.J., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS ...
- New microneedle patches for delivery of psychedelic pharmaceuticalson February 23, 2021 at 5:14 pm
Although one may think of psychedelic pharmaceuticals as being dangerous and detrimental, scientists have been conducting experiments and clinical trials on some of them and have obtained positive ...
- Pulmonary Drug Delivery Systems Market Research Report by Manufacturers, Region, Type and Application, Forecast to 2026on February 23, 2021 at 8:29 am
The global Pulmonary Drug Delivery Systems market report provides geographic analysis covering regions, such as ...
- Investors pour $8M into Raleigh medical device startup; its drug delivery tech traces roots to UNC-CHon February 19, 2021 at 12:15 pm
Advanced Chemotherapy Technologies (ACT), a medical device startup developing a way to improve the treatment of pancreatic cancer, has added $2.5 million in funding to support clinical testing of its ...
- Global Targeted Drug Delivery System Market Overview, Development Factors and Growth Analysis 2021-2026on February 17, 2021 at 10:42 pm
Feb (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global "Targeted Drug Delivery ...
- ITMO: COVID-19 Test Kits and Drug Delivery Systems: ITMO Specialists Teach Young Talents at Zerkalniy Campon February 17, 2021 at 3:13 pm
The camp on the shore of Zerkalnoye lake has been operating for over 50 years already. It is here that specialized educational sessions for St. Petersburg’s most talented children are organized on ...
- Codiak: Pioneering Engineered Exosomal Drug Deliveryon February 17, 2021 at 7:46 am
Get started today » Codiak BioSciences ( CDAK) is a recent IPO pioneering a new class of biologics, exosome therapeutics, using its engEx platform. The plan is to capture the exosome system of the ...
via Bing News